SCHEMBL250800

SCHEMBL250800

O=C1CC[CH]CC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11285608 0.87
SCHEMBL6397913 0.79
SCHEMBL290556 0.79
SCHEMBL458291 0.77
SCHEMBL6400075 0.76 TRIM24 (0.62)
Hydrochloric Acid SCHEMBL11584271 0.74
SCHEMBL29108689 0.74 TRIM24 (0.65)
SCHEMBL28674264 0.74 TRIM24 (0.65)
SCHEMBL28431028 0.74 TRIM24 (0.65)
SCHEMBL119955 0.73

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1176 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118290322-A Aromatic molecules for the treatment of pathological conditions 赛尼欧普罗有限责任公司 2024-07-05 CN claimed
US-20240140895-A1 NOVEL AROMATIC MOLECULES Xeniopro GmbH (DE) 2024-05-02 US claimed
CN-116867782-A Pyrazole amide derivative 豪夫迈·罗氏有限公司 2023-10-10 CN claimed
US-20230141913-A2 PHENOXY(HETERO)ARYL ETHERS OF ANTIPROLIFERACTIVE ACTIVITY Xeniopro GmbH (DE) 2023-05-11 US claimed
US-20220354949-A1 NOVEL COMPOUNDS Xeniopro GmbH (DE) 2022-11-10 US claimed
CN-112313234-B Pyrazolo-triazolopyrimidine derivatives as A2A receptor antagonists 百济神州有限公司 2022-04-29 CN claimed
US-20220131093-A1 METAL COMPLEX, ELECTROLUMINESCENT DEVICE INCLUDING THE SAME, AND USE THEREOF Beijing Summer Sprout Technology Co., Ltd. (CN) 2022-04-28 US claimed
US-20210198267-A1 PYRAZOLOTRIAZOLOPYRIMIDINE DERIVATIVES AS A2A RECEPTOR ANTAGONIST BEONE MEDICINES I GMBH (CH) 2021-07-01 US claimed
EP-3841095-A2 AROMATIC MOLECULES FOR USE IN THE TREATMENT OF PATHOLOGICAL CONDITIONS Xeniopro GmbH (DE) 2021-06-30 EP claimed
EP-3841091-A1 PHENOXY(HETERO)ARYL ETHERS OF ANTIPROLIFERATIVE ACTIVITY Xeniopro GmbH (DE) 2021-06-30 EP claimed
WO-1997025047-A1 NOVEL CYCLOALKYL SUBSTITUDED IMIDAZOLES SMITHKLINE BEECHAM CORPORATION (US) 1997-07-17 WO claimed
WO-1996033170-A1 N-AROYLAMINO ACID AMIDES AS ENDOTHELIN INHIBITORS NOVARITS AG (CH) 1996-10-24 WO claimed
WO-1996021654-A1 NOVEL COMPOUNDS SMITHKLINE BEECHAM CORPORATION (US) 1996-07-18 WO claimed
US-5468732-A Hypotensive PFIZER INC. (US) 1995-11-21 US claimed
EP-0385593-A1 Phosphorus containing renin inhibitors PFIZER INC. (US) 1990-09-05 EP claimed
WO-1990009172-A1 PHOSPHORUS CONTAINING RENIN INHIBITORS PFIZER INC. (US) 1990-08-23 WO claimed
US-4845224-A Cycloalkanol esters of dihydrolysergic acid having peripheral serotonin antagonist properties ELI LILLY AND COMPANY (US) 1989-07-04 US claimed
EP-0159784-B1 CARBACYCLIN ANALOGUES THE UPJOHN COMPANY (US) 1989-06-07 EP claimed
US-4816452-A ANTIBIOTICS BEECHAM GROUP P.L.C. (GB) 1989-03-28 US claimed
EP-0210815-A2 6-Beta-(alpha-etherified oxyimino)-acylamino penicillanic-acid derivatives, their preparation and use BEECHAM GROUP PLC (GB) 1987-02-04 EP claimed